1.795EUR-0.28%Mkt Cap: 155.69M EURP/E: —Last update: 2026-05-29
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as …
Industry Peers
Medical Care Facilities87.66BTRYP/E 15.5
82.76BUSDP/E 12.9
31.03BSEKP/E 36.2
19.97BEURP/E 13.2
16.19BSEKP/E 19.2
14.78BUSDP/E 8.9
12.32BUSDP/E 18.5
11.64BSEKP/E 17.0
Indicators:|
Key Statistics
Company
Market Cap155.69M EUR
Enterprise Value296.50M EUR
Revenue (TTM)270.92M EUR
Gross Profit56.14M EUR
Net Income (TTM)-4.67M EUR
Revenue/Share3.123 EUR
Last Price1.795 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees3.5K
CountryGR
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG0.93
EV/EBITDA16.90
EV/Revenue1.09
P/S0.57
P/B1.42
EPS (TTM)-0.05
EPS (Forward)—
52W Range
1.56030% of range2.350
52W High2.350 EUR
52W Low1.560 EUR
Profitability
Gross Margin20.36%
Oper. Margin5.58%
EBITDA Margin6.48%
Profit Margin-1.69%
ROE-4.49%
ROA-0.88%
Growth
Revenue Growth0.80%
Earnings Growth-85.00%
Cash Flow & Leverage
Operating CF5.09M EUR
CapEx (TTM)16.92M EUR
FCF Margin-2.75%
FCF Yield-4.78%
Net Debt139.24M EUR
Net Debt/EBITDA7.94
Balance Sheet
Debt/Equity1.76
Current Ratio0.81
Quick Ratio0.71
Book Value/Sh1.265 EUR
Cash/Share0.3020 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield2.45%
Payout Ratio0.00%
Ex-Div DateJul 22, 2024
Pay DateAug 29, 1991
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.86.74M
Float—
Insiders80.82%
Institutions0.00%
Technical
SMA 501.784 (+0.6%)
SMA 2001.913 (-6.2%)
Beta0.84
S&P 52W Chg27.94%
Avg Vol (30d)10.26K
Avg Vol (10d)5.26K
Technical Indicators
RSI (14)49.6
MACD-0.0068
MACD Signal-0.0049
MACD Hist.-0.0019
BB Upper1.860 EUR
BB Middle1.796 EUR
BB Lower1.733 EUR
BB Width7.05%
ATR (14)0.0565 EUR
Vol Ratio (20d)2.05x